Mr Baldric Kwong Shek Wat, in El Cerrito, CA - Pharmacist

Mr Baldric Kwong Shek Wat, is a Pharmacist based in El Cerrito, California. Mr Baldric Kwong Shek Wat is licensed to practice in California (license number 74016) and his current practice location is 505 Balra Dr, El Cerrito, California. He can be reached at his office (for appointments etc.) via phone at (510) 333-5210.

NPI number for Mr Baldric Kwong Shek Wat is 1538534193 and his current mailing address is 505 Balra Dr, El Cerrito, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1538534193.

Contact Information

	Mr Baldric Kwong Shek Wat,
	505 Balra Dr, El Cerrito, CA 94530-3316
	(510) 333-5210
	Not Available

Healthcare Provider's Profile

Full Name	Mr Baldric Kwong Shek Wat
Gender	Male
Speciality	Pharmacist
Location	505 Balra Dr, El Cerrito, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1538534193
Provider Enumeration Date: 12/08/2015
Last Update Date: 12/08/2015

Medical Identifiers

Medical identifiers for Mr Baldric Kwong Shek Wat such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1538534193	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	74016 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Baldric Kwong Shek Wat is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Baldric Kwong Shek Wat, 505 Balra Dr, El Cerrito, CA 94530-3316 Ph: (510) 333-5210	Mr Baldric Kwong Shek Wat, 505 Balra Dr, El Cerrito, CA 94530-3316 Ph: (510) 333-5210

News Archive

Rexahn announces results from Serdaxin Phase IIb trial on major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder.

Cigna provides data on cost, quality of services to web site

Cigna, which last year began to post cost and quality information for inpatient services performed at hospitals on a Web site for members, this week added data for outpatient services performed at stand-alone surgical centers, the Fort Worth Star-Telegram reports (Perotin, Fort Worth Star-Telegram, 9/20).

TJUH medical oncologist to receive ASCO Humanitarian Award

Edith Mitchell, M.D., FACP, a medical oncologist at Thomas Jefferson University Hospital and Jefferson's Kimmel Cancer Center (KCC) and Clinical Professor of Medicine and Medical Oncology in the Department of Medical Oncology at Jefferson Medical College of Thomas Jefferson University, has been named the 2012 recipient of the American Society of Clinical Oncology (ASCO) Humanitarian Award for her personification of the society's mission and values, and for going above and beyond the call of duty in providing outstanding patient care.

RE-LY trial results suggest Pradaxa capsule reduces risk of stroke in AF patients

Two new retrospective subanalyses of the RE-LY trial, involving Pradaxa capsules, suggested that the reduction in stroke risk achieved with PRADAXA 150mg over warfarin occurred irrespective of CHA2DS2-VASc risk score and the type of non-valvular atrial fibrillation.

NEOP receives stockholder approval to increase company shares to 205 milliion

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, announced at its 2010 Annual Meeting of Stockholders that it received the approval of its stockholders to increase the number of authorized shares of the Company from 155 million to 205 million. In addition, stockholders re-elected Neoprobe President and CEO David C. Bupp, and elected for the first time, Brendan A. Ford and Eric K. Rowinsky, M.D. as Directors of the Company for terms ending at the 2013 Annual Meeting. Stockholders also approved the appointment of BDO Seidman, LLP to act as the Company's independent registered public accounting firm for 2010.

Pharmacist in El Cerrito, CA

Mai Mohsen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11450 San Pablo Ave, El Cerrito, CA 94530 Phone: 510-233-8400
Preetinder Kaur Virk, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 670 El Cerrito Plz, El Cerrito, CA 94530 Phone: 510-524-5895
Amy Ng, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11565 San Pablo Ave, El Cerrito, CA 94530 Phone: 510-234-9300
Thanh-tam Le, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6641 Gatto Ave, El Cerrito, CA 94530 Phone: 704-383-0119
Sarah Mashreky, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10650 San Pablo Ave, El Cerrito, CA 94530 Phone: 510-527-3210
Liv Larson, PHARMD0 Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11565 San Pablo Ave, El Cerrito, CA 94530 Phone: 510-234-9300
Diana Treadway, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10650 San Pablo Ave, El Cerrito, CA 94530 Phone: 520-527-3210

Mr Baldric Kwong Shek Wat, - Pharmacist in El Cerrito, CA